Improvement in the average adjusted daily symptom score after 12 months of house dust mites subcutaneous immunotherapy: ALUMITES, a randomized, controlled, multicenter, phase IV study
Data de publicación
2015Título da revista
Allergy
Tipo de contido
Publicación de congreso